211
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study

, MD, , MD, , MD, , MD, , MD, , MD, , MD, PhD, , MD, , MD, PhD, , MD, PhD, , MD, PhD & , MD, PhD show all
Pages 915-920 | Received 15 Oct 2016, Accepted 22 Feb 2017, Published online: 24 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Mariya Doctor, Somasheila I. Murthy & Liza Rajasekhar. (2023) Tocilizumab in Recalcitrant Bilateral Scleritis in a Case of Relapsing Polychondritis: A 17-year Follow Up. Ocular Immunology and Inflammation 31:4, pages 870-873.
Read now
Carla Gaggiano, Virginia Berlengiero, Antonio Vitale, Maria Tarsia, Salvatore Grosso, Gian Marco Tosi, Francesca Ricci, Jurgen Sota, Valeria Caggiano, Bruno Frediani, Luca Cantarini, Marco Cattalini & Claudia Fabiani. (2022) The Role of Biologic Agents in the Management of Pediatric-Onset Noninfectious Posterior Scleritis. Ocular Immunology and Inflammation 0:0, pages 1-7.
Read now
Melis Kabaalioğlu Güner, Ankur Mehra & Wendy M. Smith. (2021) Novel strategies for the diagnosis and treatment of scleritis. Expert Review of Ophthalmology 16:6, pages 431-448.
Read now

Articles from other publishers (17)

Daniel Clarke, Lauren Sartor, Vu Do, Nicholas Manolios, Sanjay Swaminathan & Chameen Samarawickrama. (2023) Biologics in peripheral ulcerative keratitis. Seminars in Arthritis and Rheumatism 63, pages 152269.
Crossref
L. Perray, L. Ungerer, T. Chazal, D. Monnet, A. Brézin & B. Terrier. (2023) Sclérite et épisclérite. La Revue de Médecine Interne 44:12, pages 646-655.
Crossref
Dennis D. Arnold, Ayla Yalamanoglu & Onur Boyman. (2022) Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders. Frontiers in Immunology 13.
Crossref
Ahmad Abdel-Aty, Akash Gupta, Lucian Del Priore & Ninani Kombo. (2022) Management of noninfectious scleritis. Therapeutic Advances in Ophthalmology 14, pages 251584142110708.
Crossref
S. ShivajiS. Shivaji. 2022. Human Ocular Microbiome. Human Ocular Microbiome 253 285 .
Jurgen Sota, Matteo-Maria Girolamo, Bruno Frediani, Gian Marco Tosi, Luca Cantarini & Claudia Fabiani. (2021) Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review. Ophthalmology and Therapy 10:4, pages 777-813.
Crossref
Raul E. Ruiz-Lozano, Lucas A. Garza-Garza, Osvaldo Davila-Cavazos, C. Stephen Foster & Alejandro Rodriguez-Garcia. (2021) The clinical and pathogenic spectrum of surgically-induced scleral necrosis: A review. Survey of Ophthalmology 66:4, pages 594-611.
Crossref
Trusha Patel, Sarah E. Henrickson, Emily K. Moser, Natania S. Field, Kelly Maurer, Noor Dawany, Maire Conrad, Nancy Bunin, Jason L. Freedman, Jennifer Heimall, Danielle E. Arnold, Jing Wang, Jonathan E. Markowitz, Sarah Beth Payne-Poff, Kelli W. Williams, Pierre A. Russo, E. John Wherry, Marcella Devoto, Paula Oliver, Kathleen E. Sullivan & Judith R. Kelsen. (2021) Immune Dysregulation in Human ITCH Deficiency Successfully Treated with Hematopoietic Cell Transplantation. The Journal of Allergy and Clinical Immunology: In Practice 9:7, pages 2885-2893.e3.
Crossref
Steven E. Wilson. (2021) Interleukin-1 and Transforming Growth Factor Beta: Commonly Opposing, but Sometimes Supporting, Master Regulators of the Corneal Wound Healing Response to Injury. Investigative Opthalmology & Visual Science 62:4, pages 8.
Crossref
Seung Kwon Choi, Youn A Choi, So Hee Kim, Jae Jung Lee, Ik Soo Byon, Ji Eun Lee & Sung Who Park. (2021) The Effect of an Intravitreal Dexamethasone Implant for Refractory Posterior Scleritis. Journal of the Korean Ophthalmological Society 62:3, pages 322-328.
Crossref
Silvia Stefania, Ripalta Colia, Rotondo Cinzia, Addolorata Corrado & Francesco Paolo Cantatore. (2021) Off-label use of anti-IL-1 drugs in rheumatic diseases. International Journal of Immunopathology and Pharmacology 35, pages 205873842110065.
Crossref
Vivian Aranez & Julian AmbrusJrJr. (2019) Immunologic Adverse Effects of Biologics for the Treatment of Atopy. Clinical Reviews in Allergy & Immunology 59:2, pages 220-230.
Crossref
D.P.C. Vergouwen, A. Rothova, J.C. Ten Berge, R.M. Verdijk, J.A.M. van Laar, J.R. Vingerling & M.W.J. Schreurs. (2020) Current insights in the pathogenesis of scleritis. Experimental Eye Research 197, pages 108078.
Crossref
Alana Nevares, Robert Raut, Bonita Libman & Rula Hajj-Ali. (2020) Noninfectious Autoimmune Scleritis: Recognition, Systemic Associations, and Therapy. Current Rheumatology Reports 22:4.
Crossref
J. Michelle Kahlenberg & Insoo Kang. (2020) Advances in Disease Mechanisms and Translational Technologies: Clinicopathologic Significance of Inflammasome Activation in Autoimmune Diseases. Arthritis & Rheumatology 72:3, pages 386-395.
Crossref
Claudia Fabiani, Jurgen Sota, Maite Sainz-de-la-Maza, Laura Pelegrín, Giacomo Emmi, Giuseppe Lopalco, Florenzo Iannone, Lorenzo Vannozzi, Silvana Guerriero, Maria Chiara Gelmi, Donato Rigante, Gian Marco Tosi, José Hernández-Rodríguez & Luca Cantarini. (2020) New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy. Mediators of Inflammation 2020, pages 1-6.
Crossref
. (2018) Anakinra. Reactions Weekly 1717:1, pages 31-31.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.